Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. News
  3. Accueil
  4. Business Leaders Biography

Business Leaders
HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Kennett Sprogøe

Kennett Sprogøe
Age : 44
Public asset : 3,333 USD
Country of residence : Unknown
Linked companies : Ascendis Pharma A/S

Biography of Kennett Sprogøe 
Kennett Sprogøe occupies the position of Senior Vice President, Head-Innovation & Research at Ascendis Pharma A. Dr. Sprogøe received a doctorate from the University of Copenhagen and a graduate degree from Danmarks Farmaceutiske Universitet.


Current positions of Kennett Sprogøe 
NameTitle Since
Ascendis Pharma A/S
(Biotechnology & Medical Research)		 Senior Vice President, Head-Innovation & Research 2019


Holdings of Kennett Sprogøe 
NameEquities%Valuation
Ascendis Pharma A/S300.0001%3,333 USD


Kennett Sprogøe : Personal Network 


Most Read News 
03/17EU countries to sign agreement to buy shells for Ukraine
RE
03/20Ralph Hamers, the Dutchman thrust in the driver's seat at Swiss bank UBS
RE
03/24Musk denies report on SpaceX's plans for new funding from Saudi, UAE
RE
03/16Branson's Virgin Orbit to pause operations, shares tumble
RE
03/15BlackRock CEO Fink warns of financial risks, persistent inflation
RE
03/21UBS set for talks with Michael Klein to terminate Credit Suisse investment bank deal - FT
RE
03/15Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight
RE
03/23Elon Musk, WHO spar on Twitter over U.N. agency's role
RE
03/21Zuckerberg, Meta are sued for failing to address sex trafficking, child exploitation
RE
03/15Cucinelli raises sales growth forecast for 2023
RE
More news


© 2023 People and Ownership :   
Kennett Sprogøe : Connections 


Latest news about Kennett Sprogøe 
01/09Transcript : Ascendis Pharma A/S Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM
CI
2021Transcript : Ascendis Pharma A/S - Special Call
CI
2020Transcript : Ascendis Pharma A/S - Special Call
CI
2019Transcript : Ascendis Pharma A/S - Special Call
CI
2017Transcript : Ascendis Pharma A/S - Special Call
CI
2016Transcript : Ascendis Pharma A/S - Special Call
CI
More news
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer